Global Cephalosporine API Market Growth 2020-2025


According to this study, over the next five years the Cephalosporine API market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cephalosporine API business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Cephalosporine API market by type, application, key manufacturers and key regions and countries.

This study considers the Cephalosporine API value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
    First Generation
    Second Generation
    Third Generation
    Fourth Generation

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
    Oral
    Injection

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
    Union Chempharma
    SALUBRIS
    NCPC
    Lupin Pharmaceuticals
    Hospira
    Qilu Antibiotics
    Dongying Pharmaceutical
    Dhanuka Laboratories
    Alkem
    Fukang
    Taj Pharmaceuticals
    United Laboratories
    Covalent Laboratories
    LIVZON
    TEVA
    CSPC
    Wockhardt
    Orchid Pharma
    Hetero Drugs
    Aurobindo
    HPGC
    Huafangpharm
    LKPC

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
    To study and analyze the global Cephalosporine API consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
    To understand the structure of Cephalosporine API market by identifying its various subsegments.
    Focuses on the key global Cephalosporine API manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Cephalosporine API with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Cephalosporine API submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Research Objectives
    1.3 Years Considered
    1.4 Market Research Methodology
    1.5 Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Cephalosporine API Consumption 2015-2025
        2.1.2 Cephalosporine API Consumption CAGR by Region
    2.2 Cephalosporine API Segment by Type
        2.2.1 First Generation
        2.2.2 Second Generation
        2.2.3 Third Generation
        2.2.4 Fourth Generation
    2.3 Cephalosporine API Consumption by Type
        2.3.1 Global Cephalosporine API Consumption Market Share by Type (2015-2020)
        2.3.2 Global Cephalosporine API Revenue and Market Share by Type (2015-2020)
        2.3.3 Global Cephalosporine API Sale Price by Type (2015-2020)
    2.4 Cephalosporine API Segment by Application
        2.4.1 Oral
        2.4.2 Injection
    2.5 Cephalosporine API Consumption by Application
        2.5.1 Global Cephalosporine API Consumption Market Share by Type (2015-2020)
        2.5.2 Global Cephalosporine API Value and Market Share by Type (2015-2020)
        2.5.3 Global Cephalosporine API Sale Price by Type (2015-2020)

3 Global Cephalosporine API by Company
    3.1 Global Cephalosporine API Sales Market Share by Company
        3.1.1 Global Cephalosporine API Sales by Company (2018-2020)
        3.1.2 Global Cephalosporine API Sales Market Share by Company (2018-2020)
    3.2 Global Cephalosporine API Revenue Market Share by Company
        3.2.1 Global Cephalosporine API Revenue by Company (2018-2020)
        3.2.2 Global Cephalosporine API Revenue Market Share by Company (2018-2020)
    3.3 Global Cephalosporine API Sale Price by Company
    3.4 Global Cephalosporine API Manufacturing Base Distribution, Sales Area, Type by Company
        3.4.1 Global Cephalosporine API Manufacturing Base Distribution and Sales Area by Company
        3.4.2 Players Cephalosporine API Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 Cephalosporine API by Regions
    4.1 Cephalosporine API by Regions
    4.2 Americas Cephalosporine API Consumption Growth
    4.3 APAC Cephalosporine API Consumption Growth
    4.4 Europe Cephalosporine API Consumption Growth
    4.5 Middle East & Africa Cephalosporine API Consumption Growth

5 Americas
    5.1 Americas Cephalosporine API Consumption by Countries
        5.1.1 Americas Cephalosporine API Consumption by Countries (2015-2020)
        5.1.2 Americas Cephalosporine API Value by Countries (2015-2020)
    5.2 Americas Cephalosporine API Consumption by Type
    5.3 Americas Cephalosporine API Consumption by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
    5.8 Key Economic Indicators of Few Americas Countries

6 APAC
    6.1 APAC Cephalosporine API Consumption by Regions
        6.1.1 APAC Cephalosporine API Consumption by Regions (2015-2020)
        6.1.2 APAC Cephalosporine API Value by Regions (2015-2020)
    6.2 APAC Cephalosporine API Consumption by Type
    6.3 APAC Cephalosporine API Consumption by Application
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 Key Economic Indicators of Few APAC Regions

7 Europe
    7.1 Europe Cephalosporine API by Countries
        7.1.1 Europe Cephalosporine API Consumption by Countries (2015-2020)
        7.1.2 Europe Cephalosporine API Value by Countries (2015-2020)
    7.2 Europe Cephalosporine API Consumption by Type
    7.3 Europe Cephalosporine API Consumption by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
    7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
    8.1 Middle East & Africa Cephalosporine API by Countries
        8.1.1 Middle East & Africa Cephalosporine API Consumption by Countries (2015-2020)
        8.1.2 Middle East & Africa Cephalosporine API Value by Countries (2015-2020)
    8.2 Middle East & Africa Cephalosporine API Consumption by Type
    8.3 Middle East & Africa Cephalosporine API Consumption by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Marketing, Distributors and Customer
    10.1 Sales Channel
        10.1.1 Direct Channels
        10.1.2 Indirect Channels
    10.2 Cephalosporine API Distributors
    10.3 Cephalosporine API Customer

11 Global Cephalosporine API Market Forecast
    11.1 Global Cephalosporine API Consumption Forecast (2021-2025)
    11.2 Global Cephalosporine API Forecast by Regions
        11.2.1 Global Cephalosporine API Forecast by Regions (2021-2025)
        11.2.2 Global Cephalosporine API Value Forecast by Regions (2021-2025)
        11.2.3 Americas Consumption Forecast
        11.2.4 APAC Consumption Forecast
        11.2.5 Europe Consumption Forecast
        11.2.6 Middle East & Africa Consumption Forecast
    11.3 Americas Forecast by Countries
        11.3.1 United States Market Forecast
        11.3.2 Canada Market Forecast
        11.3.3 Mexico Market Forecast
        11.3.4 Brazil Market Forecast
   11.4 APAC Forecast by Countries
        11.4.1 China Market Forecast
        11.4.2 Japan Market Forecast
        11.4.3 Korea Market Forecast
        11.4.4 Southeast Asia Market Forecast
        11.4.5 India Market Forecast
        11.4.6 Australia Market Forecast
    11.5 Europe Forecast by Countries
        11.5.1 Germany Market Forecast
        11.5.2 France Market Forecast
        11.5.3 UK Market Forecast
        11.5.4 Italy Market Forecast
        11.5.5 Russia Market Forecast
    11.6 Middle East & Africa Forecast by Countries
        11.6.1 Egypt Market Forecast
        11.6.2 South Africa Market Forecast
        11.6.3 Israel Market Forecast
        11.6.4 Turkey Market Forecast
        11.6.5 GCC Countries Market Forecast
    11.7 Global Cephalosporine API Forecast by Type
    11.8 Global Cephalosporine API Forecast by Application

12 Key Players Analysis
    12.1 Union Chempharma
        12.1.1 Company Information
        12.1.2 Cephalosporine API Product Offered
        12.1.3 Union Chempharma Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.1.4 Main Business Overview
        12.1.5 Union Chempharma Latest Developments
    12.2 SALUBRIS
        12.2.1 Company Information
        12.2.2 Cephalosporine API Product Offered
        12.2.3 SALUBRIS Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.2.4 Main Business Overview
        12.2.5 SALUBRIS Latest Developments
    12.3 NCPC
        12.3.1 Company Information
        12.3.2 Cephalosporine API Product Offered
        12.3.3 NCPC Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.3.4 Main Business Overview
        12.3.5 NCPC Latest Developments
    12.4 Lupin Pharmaceuticals
        12.4.1 Company Information
        12.4.2 Cephalosporine API Product Offered
        12.4.3 Lupin Pharmaceuticals Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.4.4 Main Business Overview
        12.4.5 Lupin Pharmaceuticals Latest Developments
    12.5 Hospira
        12.5.1 Company Information
        12.5.2 Cephalosporine API Product Offered
        12.5.3 Hospira Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.5.4 Main Business Overview
        12.5.5 Hospira Latest Developments
    12.6 Qilu Antibiotics
        12.6.1 Company Information
        12.6.2 Cephalosporine API Product Offered
        12.6.3 Qilu Antibiotics Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.6.4 Main Business Overview
        12.6.5 Qilu Antibiotics Latest Developments
    12.7 Dongying Pharmaceutical
        12.7.1 Company Information
        12.7.2 Cephalosporine API Product Offered
        12.7.3 Dongying Pharmaceutical Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.7.4 Main Business Overview
        12.7.5 Dongying Pharmaceutical Latest Developments
    12.8 Dhanuka Laboratories
        12.8.1 Company Information
        12.8.2 Cephalosporine API Product Offered
        12.8.3 Dhanuka Laboratories Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.8.4 Main Business Overview
        12.8.5 Dhanuka Laboratories Latest Developments
    12.9 Alkem
        12.9.1 Company Information
        12.9.2 Cephalosporine API Product Offered
        12.9.3 Alkem Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.9.4 Main Business Overview
        12.9.5 Alkem Latest Developments
    12.10 Fukang
        12.10.1 Company Information
        12.10.2 Cephalosporine API Product Offered
        12.10.3 Fukang Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.10.4 Main Business Overview
        12.10.5 Fukang Latest Developments
    12.11 Taj Pharmaceuticals
        12.11.1 Company Information
        12.11.2 Cephalosporine API Product Offered
        12.11.3 Taj Pharmaceuticals Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.11.4 Main Business Overview
        12.11.5 Taj Pharmaceuticals Latest Developments
    12.12 United Laboratories
        12.12.1 Company Information
        12.12.2 Cephalosporine API Product Offered
        12.12.3 United Laboratories Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.12.4 Main Business Overview
        12.12.5 United Laboratories Latest Developments
    12.13 Covalent Laboratories
        12.13.1 Company Information
        12.13.2 Cephalosporine API Product Offered
        12.13.3 Covalent Laboratories Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.13.4 Main Business Overview
        12.13.5 Covalent Laboratories Latest Developments
    12.14 LIVZON
        12.14.1 Company Information
        12.14.2 Cephalosporine API Product Offered
        12.14.3 LIVZON Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.14.4 Main Business Overview
        12.14.5 LIVZON Latest Developments
    12.15 TEVA
        12.15.1 Company Information
        12.15.2 Cephalosporine API Product Offered
        12.15.3 TEVA Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.15.4 Main Business Overview
        12.15.5 TEVA Latest Developments
    12.16 CSPC
        12.16.1 Company Information
        12.16.2 Cephalosporine API Product Offered
        12.16.3 CSPC Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.16.4 Main Business Overview
        12.16.5 CSPC Latest Developments
    12.17 Wockhardt
        12.17.1 Company Information
        12.17.2 Cephalosporine API Product Offered
        12.17.3 Wockhardt Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.17.4 Main Business Overview
        12.17.5 Wockhardt Latest Developments
    12.18 Orchid Pharma
        12.18.1 Company Information
        12.18.2 Cephalosporine API Product Offered
        12.18.3 Orchid Pharma Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.18.4 Main Business Overview
        12.18.5 Orchid Pharma Latest Developments
    12.19 Hetero Drugs
        12.19.1 Company Information
        12.19.2 Cephalosporine API Product Offered
        12.19.3 Hetero Drugs Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.19.4 Main Business Overview
        12.19.5 Hetero Drugs Latest Developments
    12.20 Aurobindo
        12.20.1 Company Information
        12.20.2 Cephalosporine API Product Offered
        12.20.3 Aurobindo Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.20.4 Main Business Overview
        12.20.5 Aurobindo Latest Developments
    12.21 HPGC
        12.21.1 Company Information
        12.21.2 Cephalosporine API Product Offered
        12.21.3 HPGC Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.21.4 Main Business Overview
        12.21.5 HPGC Latest Developments
    12.22 Huafangpharm
        12.22.1 Company Information
        12.22.2 Cephalosporine API Product Offered
        12.22.3 Huafangpharm Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.22.4 Main Business Overview
        12.22.5 Huafangpharm Latest Developments
    12.23 LKPC
        12.23.1 Company Information
        12.23.2 Cephalosporine API Product Offered
        12.23.3 LKPC Cephalosporine API Sales, Revenue, Price and Gross Margin (2018-2020)
        12.23.4 Main Business Overview
        12.23.5 LKPC Latest Developments

13 Research Findings and Conclusion

List of Tables Table 1. Research Methodology Table 2. Data Source Table 3. Cephalosporine API Consumption CAGR by Region 2015-2025 ($ Millions) Table 4. Major Players of First Generation Table 5. Major Players of Second Generation Table 6. Major Players of Third Generation Table 7. Major Players of Fourth Generation Table 8. Global Consumption Sales by Type (2015-2020) Table 9. Global Cephalosporine API Consumption Market Share by Type (2015-2020) Table 10. Global Cephalosporine API Revenue by Type (2015-2020) ($ million) Table 11. Global Cephalosporine API Value Market Share by Type (2015-2020) ($ Millions) Table 12. Global Cephalosporine API Sale Price by Type (2015-2020) Table 13. Global Consumption Sales by Application (2015-2020) Table 14. Global Cephalosporine API Consumption Market Share by Application (2015-2020) Table 15. Global Cephalosporine API Value by Application (2015-2020) Table 16. Global Cephalosporine API Value Market Share by Application (2015-2020) Table 17. Global Cephalosporine API Sale Price by Application (2015-2020) Table 18. Global Cephalosporine API Sales by Company (2017-2019) (Kiloton) Table 19. Global Cephalosporine API Sales Market Share by Company (2017-2019) Table 20. Global Cephalosporine API Revenue by Company (2017-2019) ($ Millions) Table 21. Global Cephalosporine API Revenue Market Share by Company (2017-2019) Table 22. Global Cephalosporine API Sale Price by Company (2017-2019) Table 23. Global Cephalosporine API Manufacturing Base Distribution and Sales Area by Manufacturers Table 24. Players Cephalosporine API Products Offered Table 25. Cephalosporine API Concentration Ratio (CR3, CR5 and CR10) (2017-2019) Table 26. Global Cephalosporine API Consumption by Regions 2015-2020 (Kiloton) Table 27. Global Cephalosporine API Consumption Market Share by Regions 2015-2020 Table 28. Global Cephalosporine API Value by Regions 2015-2020 ($ Millions) Table 29. Global Cephalosporine API Value Market Share by Regions 2015-2020 Table 30. Americas Cephalosporine API Consumption by Countries (2015-2020) (Kiloton) Table 31. Americas Cephalosporine API Consumption Market Share by Countries (2015-2020) Table 32. Americas Cephalosporine API Value by Countries (2015-2020) ($ Millions) Table 33. Americas Cephalosporine API Value Market Share by Countries (2015-2020) Table 34. Americas Cephalosporine API Consumption by Type (2015-2020) (Kiloton) Table 35. Americas Cephalosporine API Consumption Market Share by Type (2015-2020) Table 36. Americas Cephalosporine API Consumption by Application (2015-2020) (Kiloton) Table 37. Americas Cephalosporine API Consumption Market Share by Application (2015-2020) Table 38. APAC Cephalosporine API Consumption by Countries (2015-2020) (Kiloton) Table 39. APAC Cephalosporine API Consumption Market Share by Countries (2015-2020) Table 40. APAC Cephalosporine API Value by Regions (2015-2020) ($ Millions) Table 41. APAC Cephalosporine API Value Market Share by Regions (2015-2020) Table 42. APAC Cephalosporine API Consumption by Type (2015-2020) (Kiloton) Table 43. APAC Cephalosporine API Consumption Market Share by Type (2015-2020) Table 44. APAC Cephalosporine API Consumption by Application (2015-2020) (Kiloton) Table 45. APAC Cephalosporine API Consumption Market Share by Application (2015-2020) Table 46. Europe Cephalosporine API Consumption by Countries (2015-2020) (Kiloton) Table 47. Europe Cephalosporine API Consumption Market Share by Countries (2015-2020) Table 48. Europe Cephalosporine API Value by Countries (2015-2020) ($ Millions) Table 49. Europe Cephalosporine API Value Market Share by Countries (2015-2020) Table 50. Europe Cephalosporine API Consumption by Type (2015-2020) (Kiloton) Table 51. Europe Cephalosporine API Consumption Market Share by Type (2015-2020) Table 52. Europe Cephalosporine API Consumption by Application (2015-2020) (Kiloton) Table 53. Europe Cephalosporine API Consumption Market Share by Application (2015-2020) Table 54. Middle East & Africa Cephalosporine API Consumption by Countries (2015-2020) (Kiloton) Table 55. Middle East & Africa Cephalosporine API Consumption Market Share by Countries (2015-2020) Table 56. Middle East & Africa Cephalosporine API Value by Countries (2015-2020) ($ Millions) Table 57. Middle East & Africa Cephalosporine API Value Market Share by Countries (2015-2020) Table 58. Middle East & Africa Cephalosporine API Consumption by Type (2015-2020) (Kiloton) Table 59. Middle East & Africa Cephalosporine API Consumption Market Share by Type (2015-2020) Table 60. Middle East & Africa Cephalosporine API Consumption by Application (2015-2020) (Kiloton) Table 61. Middle East & Africa Cephalosporine API Consumption Market Share by Application (2015-2020) Table 62. Cephalosporine API Distributors List Table 63. Cephalosporine API Customer List Table 64. Global Cephalosporine API Consumption Forecast by Countries (2021-2025) (Kiloton) Table 65. Global Cephalosporine API Consumption Market Forecast by Regions Table 66. Global Cephalosporine API Value Forecast by Countries (2021-2025) ($ Millions) Table 67. Global Cephalosporine API Value Market Share Forecast by Regions Table 68. Global Cephalosporine API Consumption Forecast by Type (2021-2025) (Kiloton) Table 69. Global Cephalosporine API Consumption Market Share Forecast by Type (2021-2025) Table 70. Global Cephalosporine API Value Forecast by Type (2021-2025) ($ Millions) Table 71. Global Cephalosporine API Value Market Share Forecast by Type (2021-2025) Table 72. Global Cephalosporine API Consumption Forecast by Application (2021-2025) (Kiloton) Table 73. Global Cephalosporine API Consumption Market Share Forecast by Application (2021-2025) Table 74. Global Cephalosporine API Value Forecast by Application (2021-2025) ($ Millions) Table 75. Global Cephalosporine API Value Market Share Forecast by Application (2021-2025) Table 76. Union Chempharma Product Offered Table 77. Union Chempharma Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 78. Union Chempharma Main Business Table 79. Union Chempharma Latest Developments Table 80. Union Chempharma Basic Information, Company Total Revenue (in $ million), Cephalosporine API Manufacturing Base, Sales Area and Its Competitors Table 81. SALUBRIS Product Offered Table 82. SALUBRIS Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 83. SALUBRIS Main Business Table 84. SALUBRIS Latest Developments Table 85. SALUBRIS Basic Information, Company Total Revenue (in $ million), Cephalosporine API Manufacturing Base, Sales Area and Its Competitors Table 86. NCPC Product Offered Table 87. NCPC Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 88. NCPC Main Business Table 89. NCPC Latest Developments Table 90. NCPC Basic Information, Company Total Revenue (in $ million), Cephalosporine API Manufacturing Base, Sales Area and Its Competitors Table 91. Lupin Pharmaceuticals Product Offered Table 92. Lupin Pharmaceuticals Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 93. Lupin Pharmaceuticals Main Business Table 94. Lupin Pharmaceuticals Latest Developments Table 95. Lupin Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Cephalosporine API Manufacturing Base, Sales Area and Its Competitors Table 96. Hospira Product Offered Table 97. Hospira Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 98. Hospira Main Business Table 99. Hospira Latest Developments Table 100. Hospira Basic Information, Company Total Revenue (in $ million), Cephalosporine API Manufacturing Base, Sales Area and Its Competitors Table 101. Qilu Antibiotics Product Offered Table 102. Qilu Antibiotics Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 103. Qilu Antibiotics Main Business Table 104. Qilu Antibiotics Latest Developments Table 105. Qilu Antibiotics Basic Information, Company Total Revenue (in $ million), Cephalosporine API Manufacturing Base, Sales Area and Its Competitors Table 106. Dongying Pharmaceutical Product Offered Table 107. Dongying Pharmaceutical Basic Information, Company Total Revenue (in $ million), Cephalosporine API Manufacturing Base, Sales Area and Its Competitors Table 108. Dongying Pharmaceutical Main Business Table 109. Dongying Pharmaceutical Latest Developments Table 110. Dongying Pharmaceutical Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 111. Dhanuka Laboratories Product Offered Table 112. Dhanuka Laboratories Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 113. Dhanuka Laboratories Main Business Table 114. Dhanuka Laboratories Latest Developments Table 115. Dhanuka Laboratories Basic Information, Company Total Revenue (in $ million), Cephalosporine API Manufacturing Base, Sales Area and Its Competitors Table 116. Alkem Product Offered Table 117. Alkem Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 118. Alkem Main Business Table 119. Alkem Latest Developments Table 120. Alkem Basic Information, Company Total Revenue (in $ million), Cephalosporine API Manufacturing Base, Sales Area and Its Competitors Table 121. Fukang Product Offered Table 122. Fukang Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 123. Fukang Main Business Table 124. Fukang Latest Developments Table 125. Fukang Basic Information, Company Total Revenue (in $ million), Cephalosporine API Manufacturing Base, Sales Area and Its Competitors Table 126. Taj Pharmaceuticals Product Offered Table 127. Taj Pharmaceuticals Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 128. Taj Pharmaceuticals Main Business Table 129. Taj Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 130. Taj Pharmaceuticals Latest Developments Table 131. United Laboratories Product Offered Table 132. United Laboratories Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 133. United Laboratories Main Business Table 134. United Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 135. United Laboratories Latest Developments Table 136. Covalent Laboratories Product Offered Table 137. Covalent Laboratories Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 138. Covalent Laboratories Main Business Table 139. Covalent Laboratories Latest Developments Table 140. Covalent Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 141. LIVZON Product Offered Table 142. LIVZON Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 143. LIVZON Main Business Table 144. LIVZON Latest Developments Table 145. LIVZON Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 146. TEVA Product Offered Table 147. TEVA Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 148. TEVA Main Business Table 149. TEVA Latest Developments Table 150. TEVA Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 151. CSPC Product Offered Table 152. CSPC Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 153. CSPC Main Business Table 154. CSPC Latest Developments Table 155. CSPC Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 156. Wockhardt Product Offered Table 157. Wockhardt Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 158. Wockhardt Main Business Table 159. Wockhardt Latest Developments Table 160. Wockhardt Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 161. Orchid Pharma Product Offered Table 162. Orchid Pharma Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 163. Orchid Pharma Main Business Table 164. Orchid Pharma Latest Developments Table 165. Orchid Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 166. Hetero Drugs Product Offered Table 167. Hetero Drugs Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 168. Hetero Drugs Main Business Table 169. Hetero Drugs Latest Developments Table 170. Hetero Drugs Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 171. Aurobindo Product Offered Table 172. Aurobindo Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 173. Aurobindo Main Business Table 174. Aurobindo Latest Developments Table 175. Aurobindo Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 176. HPGC Product Offered Table 177. HPGC Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 178. HPGC Main Business Table 179. HPGC Latest Developments Table 180. HPGC Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 181. Huafangpharm Product Offered Table 182. Huafangpharm Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 183. Huafangpharm Main Business Table 184. Huafangpharm Latest Developments Table 185. Huafangpharm Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 186. LKPC Product Offered Table 187. LKPC Cephalosporine API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E) Table 188. LKPC Main Business Table 189. LKPC Latest Developments Table 190. LKPC Basic Information, Manufacturing Base, Sales Area and Its Competitors List of Figures Figure 1. Picture of Cephalosporine API Figure 2. Cephalosporine API Report Years Considered Figure 3. Market Research Methodology Figure 4. Global Cephalosporine API Consumption Growth Rate 2015-2025 (Kiloton) Figure 5. Global Cephalosporine API Value Growth Rate 2015-2025 ($ Millions) Figure 6. Product Picture of First Generation Figure 7. Product Picture of Second Generation Figure 8. Product Picture of Third Generation Figure 9. Product Picture of Fourth Generation Figure 10. Global Cephalosporine API Consumption Market Share by Type (2015-2020) Figure 11. Global Cephalosporine API Value Market Share by Type (2015-2020) Figure 12. Cephalosporine API Consumed in Oral Figure 13. Global Cephalosporine API Market: Oral (2015-2020) (Kiloton) Figure 14. Global Cephalosporine API Market: Oral (2015-2020) ($ Millions) Figure 15. Cephalosporine API Consumed in Injection Figure 16. Global Cephalosporine API Market: Injection (2015-2020) (Kiloton) Figure 17. Global Cephalosporine API Market: Injection (2015-2020) ($ Millions) Figure 18. Global Cephalosporine API Consumption Market Share by Application (2015-2020) Figure 19. Global Cephalosporine API Value Market Share by Application (2015-2020) Figure 20. Global Cephalosporine API Sales Market Share by Company in 2017 Figure 21. Global Cephalosporine API Sales Market Share by Company in 2019 Figure 22. Global Cephalosporine API Revenue Market Share by Company in 2017 Figure 23. Global Cephalosporine API Revenue Market Share by Company in 2019 Figure 24. Global Cephalosporine API Sale Price by Company in 2019 Figure 25. Global Cephalosporine API Consumption Market Share by Regions 2015-2020 Figure 26. Global Cephalosporine API Value Market Share by Regions 2015-2020 Figure 27. Americas Cephalosporine API Consumption 2015-2020 (Kiloton) Figure 28. Americas Cephalosporine API Value 2015-2020 ($ Millions) Figure 29. APAC Cephalosporine API Consumption 2015-2020 (Kiloton) Figure 30. APAC Cephalosporine API Value 2015-2020 ($ Millions) Figure 31. Europe Cephalosporine API Consumption 2015-2020 (Kiloton) Figure 32. Europe Cephalosporine API Value 2015-2020 ($ Millions) Figure 33. Middle East & Africa Cephalosporine API Consumption 2015-2020 (Kiloton) Figure 34. Middle East & Africa Cephalosporine API Value 2015-2020 ($ Millions) Figure 35. Americas Cephalosporine API Consumption Market Share by Countries in 2019 Figure 36. Americas Cephalosporine API Value Market Share by Countries in 2019 Figure 37. Americas Cephalosporine API Consumption Market Share by Type in 2019 Figure 38. Americas Cephalosporine API Consumption Market Share by Application in 2019 Figure 39. United States Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 40. United States Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 41. Canada Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 42. Canada Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 43. Mexico Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 44. Mexico Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 45. APAC Cephalosporine API Consumption Market Share by Countries in 2019 Figure 46. APAC Cephalosporine API Value Market Share by Regions in 2019 Figure 47. APAC Cephalosporine API Consumption Market Share by Type in 2019 Figure 48. APAC Cephalosporine API Consumption Market Share by Application in 2019 Figure 49. China Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 50. China Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 51. Japan Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 52. Japan Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 53. Korea Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 54. Korea Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 55. Southeast Asia Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 56. Southeast Asia Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 57. India Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 58. India Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 59. Australia Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 60. Australia Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 61. Europe Cephalosporine API Consumption Market Share by Countries in 2019 Figure 62. Europe Cephalosporine API Value Market Share by Countries in 2019 Figure 63. Europe Cephalosporine API Consumption Market Share by Type in 2019 Figure 64. Europe Cephalosporine API Consumption Market Share by Application in 2019 Figure 65. Germany Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 66. Germany Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 67. France Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 68. France Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 69. UK Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 70. UK Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 71. Italy Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 72. Italy Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 73. Russia Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 74. Russia Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 75. Middle East & Africa Cephalosporine API Consumption Market Share by Countries in 2019 Figure 76. Middle East & Africa Cephalosporine API Value Market Share by Countries in 2019 Figure 77. Middle East & Africa Cephalosporine API Consumption Market Share by Type in 2019 Figure 78. Middle East & Africa Cephalosporine API Consumption Market Share by Application in 2019 Figure 79. Egypt Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 80. Egypt Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 81. South Africa Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 82. South Africa Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 83. Israel Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 84. Israel Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 85. Turkey Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 86. Turkey Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 87. GCC Countries Cephalosporine API Consumption Growth 2015-2020 (Kiloton) Figure 88. GCC Countries Cephalosporine API Value Growth 2015-2020 ($ Millions) Figure 89. Global Cephalosporine API Consumption Growth Rate Forecast (2021-2025) (Kiloton) Figure 90. Global Cephalosporine API Value Growth Rate Forecast (2021-2025) ($ Millions) Figure 91. Americas Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 92. Americas Cephalosporine API Value 2021-2025 ($ Millions) Figure 93. APAC Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 94. APAC Cephalosporine API Value 2021-2025 ($ Millions) Figure 95. Europe Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 96. Europe Cephalosporine API Value 2021-2025 ($ Millions) Figure 97. Middle East & Africa Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 98. Middle East & Africa Cephalosporine API Value 2021-2025 ($ Millions) Figure 99. United States Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 100. United States Cephalosporine API Value 2021-2025 ($ Millions) Figure 101. Canada Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 102. Canada Cephalosporine API Value 2021-2025 ($ Millions) Figure 103. Mexico Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 104. Mexico Cephalosporine API Value 2021-2025 ($ Millions) Figure 105. Brazil Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 106. Brazil Cephalosporine API Value 2021-2025 ($ Millions) Figure 107. China Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 108. China Cephalosporine API Value 2021-2025 ($ Millions) Figure 109. Japan Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 110. Japan Cephalosporine API Value 2021-2025 ($ Millions) Figure 111. Korea Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 112. Korea Cephalosporine API Value 2021-2025 ($ Millions) Figure 113. Southeast Asia Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 114. Southeast Asia Cephalosporine API Value 2021-2025 ($ Millions) Figure 115. India Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 116. India Cephalosporine API Value 2021-2025 ($ Millions) Figure 117. Australia Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 118. Australia Cephalosporine API Value 2021-2025 ($ Millions) Figure 119. Germany Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 120. Germany Cephalosporine API Value 2021-2025 ($ Millions) Figure 121. France Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 122. France Cephalosporine API Value 2021-2025 ($ Millions) Figure 123. UK Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 124. UK Cephalosporine API Value 2021-2025 ($ Millions) Figure 125. Italy Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 126. Italy Cephalosporine API Value 2021-2025 ($ Millions) Figure 127. Russia Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 128. Russia Cephalosporine API Value 2021-2025 ($ Millions) Figure 129. Spain Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 130. Spain Cephalosporine API Value 2021-2025 ($ Millions) Figure 131. Egypt Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 132. Egypt Cephalosporine API Value 2021-2025 ($ Millions) Figure 133. South Africa Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 134. South Africa Cephalosporine API Value 2021-2025 ($ Millions) Figure 135. Israel Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 136. Israel Cephalosporine API Value 2021-2025 ($ Millions) Figure 137. Turkey Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 138. Turkey Cephalosporine API Value 2021-2025 ($ Millions) Figure 139. GCC Countries Cephalosporine API Consumption 2021-2025 (Kiloton) Figure 140. GCC Countries Cephalosporine API Value 2021-2025 ($ Millions) Figure 141. Union Chempharma Cephalosporine API Market Share (2018-2020) Figure 142. SALUBRIS Cephalosporine API Market Share (2018-2020) Figure 143. NCPC Cephalosporine API Market Share (2018-2020) Figure 144. Lupin Pharmaceuticals Cephalosporine API Market Share (2018-2020) Figure 145. Hospira Cephalosporine API Market Share (2018-2020) Figure 146. Qilu Antibiotics Cephalosporine API Market Share (2018-2020) Figure 147. Dongying Pharmaceutical Cephalosporine API Market Share (2018-2020) Figure 148. Dhanuka Laboratories Cephalosporine API Market Share (2018-2020) Figure 149. Alkem Cephalosporine API Market Share (2018-2020) Figure 150. Fukang Cephalosporine API Market Share (2018-2020) Figure 151. Taj Pharmaceuticals Cephalosporine API Market Share (2018-2020) Figure 152. United Laboratories Cephalosporine API Market Share (2018-2020) Figure 153. Covalent Laboratories Cephalosporine API Market Share (2018-2020) Figure 154. LIVZON Cephalosporine API Market Share (2018-2020) Figure 155. TEVA Cephalosporine API Market Share (2018-2020) Figure 156. CSPC Cephalosporine API Market Share (2018-2020) Figure 157. Wockhardt Cephalosporine API Market Share (2018-2020) Figure 158. Orchid Pharma Cephalosporine API Market Share (2018-2020) Figure 159. Hetero Drugs Cephalosporine API Market Share (2018-2020) Figure 160. Aurobindo Cephalosporine API Market Share (2018-2020) Figure 161. HPGC Cephalosporine API Market Share (2018-2020) Figure 162. Huafangpharm Cephalosporine API Market Share (2018-2020) Figure 163. LKPC Cephalosporine API Market Share (2018-2020)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Chemicals and Advanced Materials Reports

Softline Coating Market Size | Global Industry Growth Report, 2025

As per credible estimates, Softline coating market is poised to acquire commendable gains by the end of 2025. Softline coatings offer additional features such as breathability, heat stability, stain & soil repellence, anti-abrasion, anti-scratch,...

Scandium Metal Market Trends and Research Insights by 2025

According to trusted estimates, global scandium metal market is projected to expand with a CAGR of 3.4% during 2020-2025 to accrue USD 78 million by the end of study period. Growing use of scandium in solid oxide fuel cells, metallurgy, ceramics, ele...

Carbon Textile Reinforced Concrete Market Research Report 2025

As per credible estimates, carbon textile reinforced concrete industry is presumed to expand with 4.7% CAGR over the next five years to amass USD 26 million by the year 2025. Growing population and increasing infrastructural development have amplifie...

Pump in Lubrication Application Market Research Report 2025

Lubrication systems use pumps for directing lubricants from the reservoir to all the lubrication points of the machine. Rapid growth of automotive and construction industries is boosting the adoption of these systems. Lubricating pumps aid in extendi...

Infrared Reflective Glazing Market Share | Industry Growth Report 2025

As per credible projections, infrared reflective glazing industry is presumed to expand with 9.7% CAGR through 2025, hence exceeding USD 2703 million by the end of study duration. Changing climatic conditions along with rising concerns regarding incr...

Other Reports by LP Information Inc

Global Narcotic (Opioid) Drugs Market Growth (Status and Outlook) 2020-2025

According to this study, over the next five years the Narcotic (Opioid) Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents ...

Global Migraine Headache Drugs Market Growth (Status and Outlook) 2020-2025

According to this study, over the next five years the Migraine Headache Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents ...

Global Type 2 Diabetes Medication Market Growth (Status and Outlook) 2020-2025

According to this study, over the next five years the Type 2 Diabetes Medication market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presen...

Global Surgical Scrub Hats Market Growth 2020-2025

According to this study, over the next five years the Surgical Scrub Hats market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the ...

Global Rizatriptan Market Growth 2020-2025

According to this study, over the next five years the Rizatriptan market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global m...

Publisher: LP Information Inc